Clinical utility of the nuclear-localized AR-V7 biomarker for treatment choice in metastatic castration-resistant prostate cancer

Transl Androl Urol. 2020 Dec;9(6):2483-2487. doi: 10.21037/tau-20-968.

Author

Virginie Vlaeminck-Guillem^{1

2}

Affiliations

¹ Centre de Recherche en Cancérologie de Lyon, INSERM 1052 CNRS UMR5286, Centre Léon Berard, Université Claude Bernard Lyon 1, Lyon, France.
² Service de Biochimie Biologie Moléculaire Sud, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite, France.

No abstract available

Publication types

Editorial
Comment